<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Repligen Corporation

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Repligen’s corporate headquarters are in Waltham, MA (USA), with additional administrative and manufacturing operations in Marlborough, MA; Bridgewater, NJ; Rancho Dominguez, CA; Lund, Sweden; Breda, The Netherlands and Ravensburg, Germany. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Tony J. Hunt
    • FOUNDED
      1981
    • EMPLOYEES
      501-1000
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Venomyx, Inc

    Venomyx, Inc

    We're developing Vipax, the world's first portable, shelf-stable, broad-spectrum a...

    We're developing Vipax, the world's first porta...

    Amount Raised:    $290,122.00
    Fundraising Status:    EC
    Filing Type:    CF
    SI-BONE, Inc.

    SI-BONE, Inc.

    SI-BONE is a medical device company that has pioneered a proprietary minimally inv...

    SI-BONE is a medical device company that has pi...

    Filing Type:    PU
    NovoCure Limited

    NovoCure Limited

    Novocure is a global oncology company working to extend survival in some of the mo...

    Novocure is a global oncology company working t...

    Filing Type:    PU
    Amgen Inc.

    Amgen Inc.

    Amgen is committed to unlocking the potential of biology for patients suffering fr...

    Amgen is committed to unlocking the potential o...

    Filing Type:    PU
    HeartIn, Inc

    HeartIn, Inc

    Founded in 2014 in Miami, Florida, HeartIn Inc. is constantly driving innovations ...

    Founded in 2014 in Miami, Florida, HeartIn Inc....

    Amount Raised:    $18,137.00
    Fundraising Status:    EC
    Filing Type:    CF
    Robovet Corporation

    Robovet Corporation

    Robovet Corporation has developed a new MR imaging technology that can also help t...

    Robovet Corporation has developed a new MR imag...

    Amount Raised:    $136,889.00
    Fundraising Status:    EC
    Filing Type:    CF
    dna ID, Inc.

    dna ID, Inc.

    The DNA ID platform is a community marketplace for genomics research. The app allo...

    The DNA ID platform is a community marketplace ...

    Amount Raised:    $57,589.00
    Fundraising Status:    EC
    Filing Type:    CF
    Medpace Holdings, Inc.

    Medpace Holdings, Inc.

    Medpace is a scientifically-driven, global, full-service clinical contract researc...

    Medpace is a scientifically-driven, global, ful...

    Filing Type:    PU
    Exelixis, Inc.

    Exelixis, Inc.

    Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncol...

    Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) ...

    Filing Type:    PU
    CryoPort, Inc.

    CryoPort, Inc.

    Cryoport is the industry’s most trusted provider of cold chain logistics solutio...

    Cryoport is the industry’s most trusted provi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.